BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/25/2025 6:14:40 AM | Browse: 68 | Download: 303
 |
Received |
|
2024-12-03 15:00 |
|
Peer-Review Started |
|
2024-12-03 15:00 |
|
First Decision by Editorial Office Director |
|
2025-01-03 09:54 |
|
Return for Revision |
|
2025-01-03 09:54 |
|
Revised |
|
2025-01-16 08:19 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-01-21 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-01-21 09:50 |
|
Articles in Press |
|
2025-01-21 09:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-02-08 03:17 |
|
Publish the Manuscript Online |
|
2025-02-25 06:14 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-You Lian, Chen-Xiao Huang, Qin-Fen Chen and Xiao-Dong Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Wenzhou Science Technology Bureau Foundation |
2022Y0726 |
|
| Corresponding Author |
Xiao-Dong Zhou, MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Lane, Wenzhou 325000, Zhejiang Province, China. zhouxiaodong@wmu.edu.cn |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Heart failure; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Sodium-glucose cotransporter 2 inhibitors |
| Core Tip |
The coexistence of heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction-associated steatotic liver disease (MASLD), poses significant clinical challenges due to their intricate relationship and similar metabolic pathophysiology. Clinical management strategies for HFpEF and MASLD still faces challenges. Sodium-glucose cotransporter 2 inhibitors showing benefits in HFpEF or MASLD, while other drugs, such as glucagon-like peptide-1 receptor agonists and statins remains under investigation. A holistic, patient-centered approach combining metabolic and cardiovascular care is vital for improving HFpEF and MASLD outcomes in global metabolic health challenges. |
| Publish Date |
2025-02-25 06:14 |
| Citation |
Lian LY, Huang CX, Chen QF, Zhou XD. Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution. World J Cardiol 2025; 17(2): 103845 |
| URL |
https://www.wjgnet.com/1949-8462/full/v17/i2/103845.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v17.i2.103845 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
